SlideShare ist ein Scribd-Unternehmen logo
1 von 3
Downloaden Sie, um offline zu lesen
Tech Mahindra
                                                                                                                                            BUY
   Target Price `338                   CMP `300.4                                                                                       FY13 PE
                                      7.6x

             Index Details            Global volumes of JLR continued to surprise (+51% yoy) and stood at
   Sensex               17,151        36,471 units in March’12. The growth momentum in volumes is expected
   Nifty                 5,243
                                      to continue in the coming year led by the robust demand of the recently
                                      launched Evoque and steady performance of the existing JLR portfolio.
   BSE 100               9,085
                                      Further, JLR which has a capacity of 3,60,000 units on a double shift
   Industry           CV & PV         basis, has started production on a three shift basis in some of its plants
                                      which can take the production to 4,10,000 units. We expect JLR to post a
             Scrip Details            volume growth of 26% in FY13 and touch ~3,98,000 units. JLR also has a
   Mkt Cap (` Cr)        80,848       strong product pipeline of 40 new variants over a period of 5 years.
                                      Launches in the near term include a new Defender and a Range Rover
   BVPS (`)                   75
                                      platform. We value Tata Motors on SOTP valuation based price objective
   O/s Shares (Cr)           269.1    of Rs. 338 (revised from previous target of Rs 292).
   Avg Vol (Lacs)            13.3




                                                                                                                                                         STOCK POINTER
   52 Week H/L          305/138                                                     SOTP Valuation
   Div Yield (%)             1.3           Company                               FY 13 EPS Multiple              Measure        Value per share

   FVPS (`)                  2.0           Tata Motors Standalone                     4.6              11           P/E                        50.6
                                           Jaguar Land Rover                         36.0              8            P/E                       270.0
                                           Tata Motors Finance                     7.3 (BV)           1.5           P/B                        10.9
     Shareholding Pattern
                                           Tata Technologies                          0.4              9            P/E                          3.8
   Shareholders               %
                                           Tata Daewoo                                0.3              9            P/E                          2.5
   Promoters                 35.1
                                           Target Price                                                                                         338
   DIIs                      14.6
   FIIs                      24.2
                                                                                      JLR Monthly Volumes
   Public                    26.1
   Total                     100


      Tata Motors vs. Sensex




                                                             Source: Tata Motors, Ventura Research Estimates

   Key Financials (` in Cr)
               Net                                                        EPS Growth           RONW            ROCE                            EV/
   Y/E Mar                 EBITDA                PAT           EPS                                                           P/E (X)
            Revenue                                                           (%)               (%)             (%)                         EBITDA(X)
   2011      92519.3        7010.9             2571.1           8.1            -                30.7            22.0          37.0             16.7
   2012E    123133.3       16514.5             9273.6          29.2         260.7               48.1            32.6          10.3             7.1
   2013E    167326.8       23042.3            11265.0          35.5          21.5               38.6            31.3           8.5             5.1
   2014E*   213347.9       29589.8            18350.4          57.8          62.9               39.8            33.5           5.2             4.0
                                                                                                                                       th
- 1 of 6 -                                                                                                                      Tuesday 27 March, 2012
                        This document is for private circulation, and must be read in conjunction with the disclaimer on the last page.
Financials and Projections (Consolidated)

       Y/E March, Fig in Rs. Cr     FY 2010     FY 2011    FY 2012e   FY 2013e     Y/E March, Fig in Rs. Cr            FY 2010    FY 2011     FY 2012e    FY 2013e
       Profit & Loss Statement                                                     Per Share Data (Rs)
       Net Sales                     92519.3 123133.3 167326.8        213347.9     EPS                                      8.1       29.2        35.5        57.8
       % Chg.                                  33.1%    35.9%           27.5%      Cash EPS                                20.4       43.9        52.3        77.5
       Total Expenditure             85508.4 106618.8 144284.5        183758.1     DPS                                      3.0        4.0         4.0         4.0
       % Chg.                                  24.7%    35.3%           27.4%      Book Value                              25.9       60.4        91.4       144.6
       EBDITA                         7010.9 16514.5 23042.3           29589.8     Capital, Liquidity, Returns Ratio
       EBDITA Margin %                   7.6     13.4     13.8            13.9     Debt / Equity (x)                        4.3        1.7         1.5          1.0
       Other Income                   3123.8    732.4    992.8          1238.7     Current Ratio (x)                        1.0        1.1         1.2          1.3
       Exceptional Items              -259.6    231.0   -660.0             0.0     ROE (%)                                 30.7       48.1        38.6         39.8
       PBDIT                          9875.1 17478.0 23375.1           30828.5     ROCE (%)                                22.0       32.6        31.3         33.5
       Depreciation                   3887.1   4655.5   5343.7          6231.7     Dividend Yield (%)                       1.0        1.3         1.3          1.3
       Interest                       2465.3   2385.3   3693.8          3722.0     Valuation Ratio (x)
       PBT                            3522.6 10437.2 14337.6           20874.7     P/E                                     37.0       10.3          8.5         5.2
       Tax Provisions                 1005.8   1216.4   3139.3          2609.3     P/BV                                    11.6        5.0          3.3         2.1
       PAT                            2516.9   9220.8 11198.3          18265.4     EV/Sales                                 1.3        1.0          0.7         0.5
       Minority Interest & Others       54.2     52.8     66.7            85.0     EV/EBIDTA                               16.7        7.1          5.1         4.0
       Consolidated Net Profit        2571.1   9273.6 11265.0          18350.4     Efficiency Ratio (x)
       PAT Margin (%)                    2.7      7.5      6.7             8.6     Inventory (days)                        44.9       41.9        42.0        42.0
       Raw Materials / Sales (%)        67.0     64.6     66.5            66.5     Debtors (days)                          28.6       20.5        20.0        20.0
       Tax Rate (%)                     28.6     11.7     12.0            12.5     Creditors (days)                       135.4      110.7       110.0       110.0

       Balance Sheet                                                               Cash Flow statement
       Share Capital                   570.6       637.7      637.7      637.7     Profit After Tax                      2571.1     9273.6     11265.0      18350.4
       Reserves & Surplus             7635.9     18533.8    28348.1    45247.8     Depreciation                          3887.1     4655.5      5343.7       6231.7
       Minority Interest & Others      213.5       246.6      296.6      360.4     Working Capital Changes               4626.0    -1431.8      1692.4       2355.9
       Total Loans                   35299.5     32791.4    43973.3    44399.2     Others                               -3391.4     -504.6        45.6         55.9
       Deferred Tax Liability         1153.6      1463.8     1463.8     1463.8     Operating Cash Flow                   7692.8    11992.7     18346.7      26993.9
       Total Liabilities             44873.1     53673.3    74719.5    92108.9     Capital Expenditure                  -5057.6    -7802.1    -16000.0     -15000.0
       Goodwill                          0.0         0.0        0.0        0.0     Change in Investment                   655.4    -3138.1      -394.2        -32.0
       Gross Block                  67245.67     75047.7    91047.7   106047.7     Cash Flow from Investing            -4402.28   -10940.1    -16394.2     -15032.0
       Less: Acc. Depreciation       34232.4     39698.7    45042.4    51274.1     Proceeds from equity issue            1404.8     4703.2         0.0          0.0
       Net Block                     33013.3     35349.1    46005.3    54773.6     Inc/ Dec in Debt                       325.7    -2508.1     11181.9        425.9
       Capital Work in Progress       8915.9     11728.9    10500.0    10500.0     Dividend and DDT                      -344.9     -990.2     -1450.7      -1450.7
       Investments                    2219.1      2544.3     4167.3     4199.3     Cash Flow from Financing              1385.6     1204.9      9731.2      -1024.8
       Net Current Assets              724.8      4051.1    14042.4    22623.6     Net Change in Cash                    4676.2     2257.4     11683.7      10937.1
       Misc Expenses                     0.0         0.0        0.0        0.0     Opening Cash Balance                  4121.3     8743.3     10947.9      22631.6
       Total Assets                  44873.1     53673.3    74719.5    92108.8     Closing Cash Balance                  8797.5    11000.8     22631.6      33568.7




  Ventura Securities Limited

  Corporate Office: C-112/116, Bldg No. 1, Kailash Industrial Complex, Park Site, Vikhroli (W), Mumbai – 400079

  This report is neither an offer nor a solicitation to purchase or sell securities. The information and views expressed herein are believed to be reliable, but
  no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in or have positions in the securities

- 2 of 6-                                                                                                                                   Tuesday 27 th March, 2012
                    This document is for private circulation, and must be read in conjunction with the disclaimer on the last page.
mentioned in their articles. Neither Ventura Securities Limited nor any of the contributors accepts any liability arising out of the above information/articles.
  Reproduction in whole or in part without written permission is prohibited. This report is for private circulation.




- 3 of 6-                                                                                                                               Tuesday 27 th March, 2012
                   This document is for private circulation, and must be read in conjunction with the disclaimer on the last page.

Weitere ähnliche Inhalte

Was ist angesagt? (17)

GSPL
GSPLGSPL
GSPL
 
Sun TV
Sun TVSun TV
Sun TV
 
Weekly Fundamental Review Company Report( 21st 27th Feb 2010)
Weekly Fundamental Review  Company Report( 21st 27th Feb 2010)Weekly Fundamental Review  Company Report( 21st 27th Feb 2010)
Weekly Fundamental Review Company Report( 21st 27th Feb 2010)
 
Deutsche EuroShop | Company Presentation | 03/13 (Preliminary Results)
Deutsche EuroShop | Company Presentation | 03/13 (Preliminary Results)Deutsche EuroShop | Company Presentation | 03/13 (Preliminary Results)
Deutsche EuroShop | Company Presentation | 03/13 (Preliminary Results)
 
Apollo Tyres
Apollo TyresApollo Tyres
Apollo Tyres
 
Sarda Energy
Sarda EnergySarda Energy
Sarda Energy
 
Finolex Cables
Finolex CablesFinolex Cables
Finolex Cables
 
Deutsche EuroShop | Company Presentation | 10/12
Deutsche EuroShop | Company Presentation | 10/12Deutsche EuroShop | Company Presentation | 10/12
Deutsche EuroShop | Company Presentation | 10/12
 
Ambuja ru1 qcy2010-230410
Ambuja ru1 qcy2010-230410Ambuja ru1 qcy2010-230410
Ambuja ru1 qcy2010-230410
 
Ambuja Cement
Ambuja CementAmbuja Cement
Ambuja Cement
 
Deutsche EuroShop | Company Presentation | 09/12
Deutsche EuroShop | Company Presentation | 09/12Deutsche EuroShop | Company Presentation | 09/12
Deutsche EuroShop | Company Presentation | 09/12
 
Glaxo Result Update
Glaxo Result UpdateGlaxo Result Update
Glaxo Result Update
 
Madras cements ru4 qfy2010-250510
Madras cements ru4 qfy2010-250510Madras cements ru4 qfy2010-250510
Madras cements ru4 qfy2010-250510
 
Deutsche EuroShop | Company Presentation | 07/12
Deutsche EuroShop | Company Presentation | 07/12Deutsche EuroShop | Company Presentation | 07/12
Deutsche EuroShop | Company Presentation | 07/12
 
India Cement
India CementIndia Cement
India Cement
 
Ntpc ru4 qfy2010-190510
Ntpc ru4 qfy2010-190510Ntpc ru4 qfy2010-190510
Ntpc ru4 qfy2010-190510
 
Sesa Goa - Result Update
Sesa Goa  - Result Update Sesa Goa  - Result Update
Sesa Goa - Result Update
 

Andere mochten auch

Hadoop java tdc 2014
Hadoop java   tdc 2014Hadoop java   tdc 2014
Hadoop java tdc 2014
Aldrin Leal
 
Hadoop - TDC FLN 2013
Hadoop - TDC FLN 2013Hadoop - TDC FLN 2013
Hadoop - TDC FLN 2013
Aldrin Leal
 
Presentasi Pestisida 2)
Presentasi Pestisida 2)Presentasi Pestisida 2)
Presentasi Pestisida 2)
guestf9feca
 

Andere mochten auch (14)

Grazie a Tutti CRF
Grazie a Tutti  CRFGrazie a Tutti  CRF
Grazie a Tutti CRF
 
Biebwatch: leesbevordering in het VMBO
Biebwatch: leesbevordering in het VMBOBiebwatch: leesbevordering in het VMBO
Biebwatch: leesbevordering in het VMBO
 
Hadoop java tdc 2014
Hadoop java   tdc 2014Hadoop java   tdc 2014
Hadoop java tdc 2014
 
First insights cairn india ltd
First insights  cairn india ltdFirst insights  cairn india ltd
First insights cairn india ltd
 
Cerrando Capitulos
Cerrando CapitulosCerrando Capitulos
Cerrando Capitulos
 
Vivimed labs ltd
Vivimed labs ltdVivimed labs ltd
Vivimed labs ltd
 
Cairn india ltd q3 fy12 result update
Cairn india ltd q3 fy12 result updateCairn india ltd q3 fy12 result update
Cairn india ltd q3 fy12 result update
 
Hadoop - TDC FLN 2013
Hadoop - TDC FLN 2013Hadoop - TDC FLN 2013
Hadoop - TDC FLN 2013
 
PanMediaNEWS_2009_23_Railvision.pdf
PanMediaNEWS_2009_23_Railvision.pdfPanMediaNEWS_2009_23_Railvision.pdf
PanMediaNEWS_2009_23_Railvision.pdf
 
Sunshine Coast Tourism Reseach Sept 2009
Sunshine Coast Tourism Reseach Sept 2009Sunshine Coast Tourism Reseach Sept 2009
Sunshine Coast Tourism Reseach Sept 2009
 
Sunshine Coast Tourism Reseach June 2009
Sunshine Coast Tourism Reseach June 2009Sunshine Coast Tourism Reseach June 2009
Sunshine Coast Tourism Reseach June 2009
 
Ocl India - Explosive Growth Ahead
Ocl India - Explosive Growth AheadOcl India - Explosive Growth Ahead
Ocl India - Explosive Growth Ahead
 
Presentasi Pestisida 2)
Presentasi Pestisida 2)Presentasi Pestisida 2)
Presentasi Pestisida 2)
 
South Indian Bank
South Indian BankSouth Indian Bank
South Indian Bank
 

Ähnlich wie Tata motors update (20)

Ultratech Cement
Ultratech Cement Ultratech Cement
Ultratech Cement
 
L&t ru4 qfy2010-170510
L&t ru4 qfy2010-170510L&t ru4 qfy2010-170510
L&t ru4 qfy2010-170510
 
Areva TD
Areva TDAreva TD
Areva TD
 
Bajaj Electricals
Bajaj ElectricalsBajaj Electricals
Bajaj Electricals
 
Gipcl
Gipcl Gipcl
Gipcl
 
FAG Bearing
FAG BearingFAG Bearing
FAG Bearing
 
JP Associates
JP AssociatesJP Associates
JP Associates
 
Larsen & Tourbo
Larsen & TourboLarsen & Tourbo
Larsen & Tourbo
 
Exide
Exide Exide
Exide
 
Glaxo - Result Update
Glaxo - Result UpdateGlaxo - Result Update
Glaxo - Result Update
 
Exide Industries
Exide IndustriesExide Industries
Exide Industries
 
Cesc
Cesc Cesc
Cesc
 
Tata motors ru4 qfy2010-280510
Tata motors  ru4 qfy2010-280510Tata motors  ru4 qfy2010-280510
Tata motors ru4 qfy2010-280510
 
Madras Cements
Madras CementsMadras Cements
Madras Cements
 
Maruti
Maruti Maruti
Maruti
 
Crompton Greaves
Crompton Greaves Crompton Greaves
Crompton Greaves
 
Sadbhav
SadbhavSadbhav
Sadbhav
 
SpiceJet
SpiceJetSpiceJet
SpiceJet
 
Mcnally Bharat
Mcnally BharatMcnally Bharat
Mcnally Bharat
 
GSPL
GSPLGSPL
GSPL
 

Mehr von Vinit Bolinjkar LION bolinjkar.vinit@gmail.com

India Union Budget 2014-15 | A Holistic Plan of Action
India Union Budget 2014-15 | A Holistic Plan of ActionIndia Union Budget 2014-15 | A Holistic Plan of Action
India Union Budget 2014-15 | A Holistic Plan of Action
Vinit Bolinjkar LION bolinjkar.vinit@gmail.com
 
Indian_Pharma_Sector_Technical_Outlook_Dec_2012
Indian_Pharma_Sector_Technical_Outlook_Dec_2012Indian_Pharma_Sector_Technical_Outlook_Dec_2012
Indian_Pharma_Sector_Technical_Outlook_Dec_2012
Vinit Bolinjkar LION bolinjkar.vinit@gmail.com
 
Petronet lng
Petronet lngPetronet lng
Initiating coverage Mahindra & Mahindra ltd
Initiating coverage  Mahindra & Mahindra ltdInitiating coverage  Mahindra & Mahindra ltd
Initiating coverage Mahindra & Mahindra ltd
Vinit Bolinjkar LION bolinjkar.vinit@gmail.com
 

Mehr von Vinit Bolinjkar LION bolinjkar.vinit@gmail.com (20)

Burger King Equity Research & Valuation Webinar Slide Deck| School of Market ...
Burger King Equity Research & Valuation Webinar Slide Deck| School of Market ...Burger King Equity Research & Valuation Webinar Slide Deck| School of Market ...
Burger King Equity Research & Valuation Webinar Slide Deck| School of Market ...
 
Varun Beverages Equity Research & Valuation | School of Market Studies Webina...
Varun Beverages Equity Research & Valuation | School of Market Studies Webina...Varun Beverages Equity Research & Valuation | School of Market Studies Webina...
Varun Beverages Equity Research & Valuation | School of Market Studies Webina...
 
Voltas Equity Research & Valuation | School of Market Studies Webinar Learnin...
Voltas Equity Research & Valuation | School of Market Studies Webinar Learnin...Voltas Equity Research & Valuation | School of Market Studies Webinar Learnin...
Voltas Equity Research & Valuation | School of Market Studies Webinar Learnin...
 
HUL Equity Research & Valuation | School of Market Studies Webinar Learning S...
HUL Equity Research & Valuation | School of Market Studies Webinar Learning S...HUL Equity Research & Valuation | School of Market Studies Webinar Learning S...
HUL Equity Research & Valuation | School of Market Studies Webinar Learning S...
 
Get LinkedIn₹ - Ask Me Anything
Get LinkedIn₹ - Ask Me AnythingGet LinkedIn₹ - Ask Me Anything
Get LinkedIn₹ - Ask Me Anything
 
#Coronavirus Important Facts We Should Know
#Coronavirus Important Facts We Should Know#Coronavirus Important Facts We Should Know
#Coronavirus Important Facts We Should Know
 
Metal Pipe Stocks - Technical Analysis (Weekly Charts)
Metal Pipe Stocks - Technical Analysis (Weekly Charts)Metal Pipe Stocks - Technical Analysis (Weekly Charts)
Metal Pipe Stocks - Technical Analysis (Weekly Charts)
 
Webinar: 10 Businesses With Superlative Moats
Webinar: 10 Businesses With Superlative MoatsWebinar: 10 Businesses With Superlative Moats
Webinar: 10 Businesses With Superlative Moats
 
Multibagger stock picking_using_8_criteria_elimination
Multibagger stock picking_using_8_criteria_eliminationMultibagger stock picking_using_8_criteria_elimination
Multibagger stock picking_using_8_criteria_elimination
 
Dematerialization: A Silent Revolution in the Indian Capital Markets
Dematerialization: A Silent Revolution in the Indian Capital MarketsDematerialization: A Silent Revolution in the Indian Capital Markets
Dematerialization: A Silent Revolution in the Indian Capital Markets
 
India Union Budget 2014-15 | A Holistic Plan of Action
India Union Budget 2014-15 | A Holistic Plan of ActionIndia Union Budget 2014-15 | A Holistic Plan of Action
India Union Budget 2014-15 | A Holistic Plan of Action
 
Technical analysis-select-commodities-april-2013
Technical analysis-select-commodities-april-2013Technical analysis-select-commodities-april-2013
Technical analysis-select-commodities-april-2013
 
India budget-2013-14
India budget-2013-14India budget-2013-14
India budget-2013-14
 
Indian_Pharma_Sector_Technical_Outlook_Dec_2012
Indian_Pharma_Sector_Technical_Outlook_Dec_2012Indian_Pharma_Sector_Technical_Outlook_Dec_2012
Indian_Pharma_Sector_Technical_Outlook_Dec_2012
 
Initiating coverage gmdc_ltd_buy_for_36_per_appreciation
Initiating coverage gmdc_ltd_buy_for_36_per_appreciationInitiating coverage gmdc_ltd_buy_for_36_per_appreciation
Initiating coverage gmdc_ltd_buy_for_36_per_appreciation
 
Divis' lab ltd
Divis' lab ltdDivis' lab ltd
Divis' lab ltd
 
Wockhardt ltd result update
Wockhardt ltd result updateWockhardt ltd result update
Wockhardt ltd result update
 
Petronet lng
Petronet lngPetronet lng
Petronet lng
 
Initiating coverage Mahindra & Mahindra ltd
Initiating coverage  Mahindra & Mahindra ltdInitiating coverage  Mahindra & Mahindra ltd
Initiating coverage Mahindra & Mahindra ltd
 
Wockhardt ltd
Wockhardt ltdWockhardt ltd
Wockhardt ltd
 

Kürzlich hochgeladen

Presentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelledPresentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelled
CaitlinCummins3
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Pusat Herbal Resmi BPOM
 
Powerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metricsPowerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metrics
CaitlinCummins3
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
seri bangash
 
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
daisycvs
 

Kürzlich hochgeladen (20)

PitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for StartupsPitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for Startups
 
Presentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelledPresentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelled
 
Unlocking Growth The Power of Outsourcing for CPA Firms
Unlocking Growth The Power of Outsourcing for CPA FirmsUnlocking Growth The Power of Outsourcing for CPA Firms
Unlocking Growth The Power of Outsourcing for CPA Firms
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
 
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdfProgress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
 
How Do Venture Capitalists Make Decisions?
How Do Venture Capitalists Make Decisions?How Do Venture Capitalists Make Decisions?
How Do Venture Capitalists Make Decisions?
 
How to refresh to be fit for the future world
How to refresh to be fit for the future worldHow to refresh to be fit for the future world
How to refresh to be fit for the future world
 
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptxGoal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
 
Beyond Numbers A Holistic Approach to Forensic Accounting
Beyond Numbers A Holistic Approach to Forensic AccountingBeyond Numbers A Holistic Approach to Forensic Accounting
Beyond Numbers A Holistic Approach to Forensic Accounting
 
hyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementshyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statements
 
MEANING AND CHARACTERISTICS OF TAXATION.
MEANING AND CHARACTERISTICS OF TAXATION.MEANING AND CHARACTERISTICS OF TAXATION.
MEANING AND CHARACTERISTICS OF TAXATION.
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings release
 
Powerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metricsPowerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metrics
 
Navigating Tax Season with Confidence Streamlines CPA Firms
Navigating Tax Season with Confidence Streamlines CPA FirmsNavigating Tax Season with Confidence Streamlines CPA Firms
Navigating Tax Season with Confidence Streamlines CPA Firms
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
 
Moradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in PenacovaMoradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in Penacova
 
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
 
Elevate Your Online Presence with SEO Services
Elevate Your Online Presence with SEO ServicesElevate Your Online Presence with SEO Services
Elevate Your Online Presence with SEO Services
 
Raising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesRaising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE Ventures
 
WAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdfWAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdf
 

Tata motors update

  • 1. Tech Mahindra BUY Target Price `338 CMP `300.4 FY13 PE 7.6x Index Details Global volumes of JLR continued to surprise (+51% yoy) and stood at Sensex 17,151 36,471 units in March’12. The growth momentum in volumes is expected Nifty 5,243 to continue in the coming year led by the robust demand of the recently launched Evoque and steady performance of the existing JLR portfolio. BSE 100 9,085 Further, JLR which has a capacity of 3,60,000 units on a double shift Industry CV & PV basis, has started production on a three shift basis in some of its plants which can take the production to 4,10,000 units. We expect JLR to post a Scrip Details volume growth of 26% in FY13 and touch ~3,98,000 units. JLR also has a Mkt Cap (` Cr) 80,848 strong product pipeline of 40 new variants over a period of 5 years. Launches in the near term include a new Defender and a Range Rover BVPS (`) 75 platform. We value Tata Motors on SOTP valuation based price objective O/s Shares (Cr) 269.1 of Rs. 338 (revised from previous target of Rs 292). Avg Vol (Lacs) 13.3 STOCK POINTER 52 Week H/L 305/138 SOTP Valuation Div Yield (%) 1.3 Company FY 13 EPS Multiple Measure Value per share FVPS (`) 2.0 Tata Motors Standalone 4.6 11 P/E 50.6 Jaguar Land Rover 36.0 8 P/E 270.0 Tata Motors Finance 7.3 (BV) 1.5 P/B 10.9 Shareholding Pattern Tata Technologies 0.4 9 P/E 3.8 Shareholders % Tata Daewoo 0.3 9 P/E 2.5 Promoters 35.1 Target Price 338 DIIs 14.6 FIIs 24.2 JLR Monthly Volumes Public 26.1 Total 100 Tata Motors vs. Sensex Source: Tata Motors, Ventura Research Estimates Key Financials (` in Cr) Net EPS Growth RONW ROCE EV/ Y/E Mar EBITDA PAT EPS P/E (X) Revenue (%) (%) (%) EBITDA(X) 2011 92519.3 7010.9 2571.1 8.1 - 30.7 22.0 37.0 16.7 2012E 123133.3 16514.5 9273.6 29.2 260.7 48.1 32.6 10.3 7.1 2013E 167326.8 23042.3 11265.0 35.5 21.5 38.6 31.3 8.5 5.1 2014E* 213347.9 29589.8 18350.4 57.8 62.9 39.8 33.5 5.2 4.0 th - 1 of 6 - Tuesday 27 March, 2012 This document is for private circulation, and must be read in conjunction with the disclaimer on the last page.
  • 2. Financials and Projections (Consolidated) Y/E March, Fig in Rs. Cr FY 2010 FY 2011 FY 2012e FY 2013e Y/E March, Fig in Rs. Cr FY 2010 FY 2011 FY 2012e FY 2013e Profit & Loss Statement Per Share Data (Rs) Net Sales 92519.3 123133.3 167326.8 213347.9 EPS 8.1 29.2 35.5 57.8 % Chg. 33.1% 35.9% 27.5% Cash EPS 20.4 43.9 52.3 77.5 Total Expenditure 85508.4 106618.8 144284.5 183758.1 DPS 3.0 4.0 4.0 4.0 % Chg. 24.7% 35.3% 27.4% Book Value 25.9 60.4 91.4 144.6 EBDITA 7010.9 16514.5 23042.3 29589.8 Capital, Liquidity, Returns Ratio EBDITA Margin % 7.6 13.4 13.8 13.9 Debt / Equity (x) 4.3 1.7 1.5 1.0 Other Income 3123.8 732.4 992.8 1238.7 Current Ratio (x) 1.0 1.1 1.2 1.3 Exceptional Items -259.6 231.0 -660.0 0.0 ROE (%) 30.7 48.1 38.6 39.8 PBDIT 9875.1 17478.0 23375.1 30828.5 ROCE (%) 22.0 32.6 31.3 33.5 Depreciation 3887.1 4655.5 5343.7 6231.7 Dividend Yield (%) 1.0 1.3 1.3 1.3 Interest 2465.3 2385.3 3693.8 3722.0 Valuation Ratio (x) PBT 3522.6 10437.2 14337.6 20874.7 P/E 37.0 10.3 8.5 5.2 Tax Provisions 1005.8 1216.4 3139.3 2609.3 P/BV 11.6 5.0 3.3 2.1 PAT 2516.9 9220.8 11198.3 18265.4 EV/Sales 1.3 1.0 0.7 0.5 Minority Interest & Others 54.2 52.8 66.7 85.0 EV/EBIDTA 16.7 7.1 5.1 4.0 Consolidated Net Profit 2571.1 9273.6 11265.0 18350.4 Efficiency Ratio (x) PAT Margin (%) 2.7 7.5 6.7 8.6 Inventory (days) 44.9 41.9 42.0 42.0 Raw Materials / Sales (%) 67.0 64.6 66.5 66.5 Debtors (days) 28.6 20.5 20.0 20.0 Tax Rate (%) 28.6 11.7 12.0 12.5 Creditors (days) 135.4 110.7 110.0 110.0 Balance Sheet Cash Flow statement Share Capital 570.6 637.7 637.7 637.7 Profit After Tax 2571.1 9273.6 11265.0 18350.4 Reserves & Surplus 7635.9 18533.8 28348.1 45247.8 Depreciation 3887.1 4655.5 5343.7 6231.7 Minority Interest & Others 213.5 246.6 296.6 360.4 Working Capital Changes 4626.0 -1431.8 1692.4 2355.9 Total Loans 35299.5 32791.4 43973.3 44399.2 Others -3391.4 -504.6 45.6 55.9 Deferred Tax Liability 1153.6 1463.8 1463.8 1463.8 Operating Cash Flow 7692.8 11992.7 18346.7 26993.9 Total Liabilities 44873.1 53673.3 74719.5 92108.9 Capital Expenditure -5057.6 -7802.1 -16000.0 -15000.0 Goodwill 0.0 0.0 0.0 0.0 Change in Investment 655.4 -3138.1 -394.2 -32.0 Gross Block 67245.67 75047.7 91047.7 106047.7 Cash Flow from Investing -4402.28 -10940.1 -16394.2 -15032.0 Less: Acc. Depreciation 34232.4 39698.7 45042.4 51274.1 Proceeds from equity issue 1404.8 4703.2 0.0 0.0 Net Block 33013.3 35349.1 46005.3 54773.6 Inc/ Dec in Debt 325.7 -2508.1 11181.9 425.9 Capital Work in Progress 8915.9 11728.9 10500.0 10500.0 Dividend and DDT -344.9 -990.2 -1450.7 -1450.7 Investments 2219.1 2544.3 4167.3 4199.3 Cash Flow from Financing 1385.6 1204.9 9731.2 -1024.8 Net Current Assets 724.8 4051.1 14042.4 22623.6 Net Change in Cash 4676.2 2257.4 11683.7 10937.1 Misc Expenses 0.0 0.0 0.0 0.0 Opening Cash Balance 4121.3 8743.3 10947.9 22631.6 Total Assets 44873.1 53673.3 74719.5 92108.8 Closing Cash Balance 8797.5 11000.8 22631.6 33568.7 Ventura Securities Limited Corporate Office: C-112/116, Bldg No. 1, Kailash Industrial Complex, Park Site, Vikhroli (W), Mumbai – 400079 This report is neither an offer nor a solicitation to purchase or sell securities. The information and views expressed herein are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in or have positions in the securities - 2 of 6- Tuesday 27 th March, 2012 This document is for private circulation, and must be read in conjunction with the disclaimer on the last page.
  • 3. mentioned in their articles. Neither Ventura Securities Limited nor any of the contributors accepts any liability arising out of the above information/articles. Reproduction in whole or in part without written permission is prohibited. This report is for private circulation. - 3 of 6- Tuesday 27 th March, 2012 This document is for private circulation, and must be read in conjunction with the disclaimer on the last page.